In terms of Cervarix, the vaccine product used in Scotland, evidence from clinical trials has demonstrated that the vaccine provides protection against cervical infection and pre-cancer caused by oncogenic HPV types for at least six years. Protection is expected to last for much longer.

We will consider this as part of the work to prepare a Dementia Strategy for Scotland.

Any decision about the Community Health Nurse Pilots will be dependent on the outcome of the interim evaluation which will be completed by the end of December 2009.

We are examining the available information and will write to the member as soon as possible. A copy will also be placed in the Scottish Parliament Information Centre (Bib. number 48588).

It is the responsibility of local partners to ensure that appropriate services are in place to enable people with drug and alcohol problems to recover. It is then for clinicians and practitioners to work with individual service users to identify the most relevant form of treatment that is right for them, based on their needs.

We are currently working with health boards and other partners to develop waiting times targets for alcohol and drug services. As part of this we will be discussing the extent to which current and possible future capacity of a range of services, including residential rehabilitation, is proportionate to the range of possible targets, and any resource implications.

The Scottish Government has set up an Architecture and Design Division within the eHealth programme to promote the progressive integration of NHS Scotland systems. Procurement such as those for General Practice and Patient Management systems include the requirement to interface with existing systems to facilitate the appropriate transmission of information.

The eHealth Programme Board provides governance over projects funded by the Scottish Government eHealth Directorate. For a project to be approved by the board, a business case must be submitted. Every business case must include details of how that project will be evaluated.

The eHealth Programme Board requires that the business case for any project funded by Scottish Government eHealth Directorate includes details of how the project will be evaluated. Project evaluation should address: measurable quality improvements; benefits realisation, and, where appropriate, efficiency savings. Projects must report regularly to the eHealth Programme Management Office, including details of progress against planned milestones, risks and issues.

I have asked Mike Ewart, Chief Executive of the Scottish Prison Service, to respond. His response is as follows:

In the event of segregation, there is a high risk that the experience may damage mental health. According to the World Health Organization, prisoners held in isolation or segregation may experience increased anxiety, visual hallucinations and psychotic-type symptoms, as well as loss of memory and impaired concentration and an increased risk of suicide; and that such symptoms and behaviours can develop unbeknown to staff. Additionally people who have suffered severe and repeated traumas in childhood and their youth may be especially prone to stress response syndromes.

Scottish prisons take all reasonable measures to avoid the segregation of prisoners with severe and enduring mental health problems.

I have asked Mike Ewart, Chief Executive of the Scottish Prison Service (SPS), to respond. His response is as follows:

The National Programme Board for Prisoners'' Healthcare will oversees and steers the preparatory work, and the eventual operational transfer of the responsibility of the primary healthcare services from the SPS to NHS boards.

Mr John Ross CBE has been appointed as Chair of the National Programme Board for Prisoners'' Healthcare.

The membership of the board is made up of NHS and SPS senior staff, NHS and SPS staff organisations, Scottish Government staff and representatives of service users.

Currently, individual prisoners requiring specialist care transfer to the NHS for health care and treatment, returning to prison care when clinically appropriate.